Ongoing efforts by the U.S. Fish and Wildlife Service have been directed toward expanding the current approval of 35% PEROX-AID® for control of mortality caused by external columnaris to include all freshwater-reared, warmwater finfish. As such, and with concurrence from FDA/CVM, we designed and coordinated a controlled field trial to evaluate the efficacy of 35% PEROX-AID® to control mortality in bluegill (BLG) Lepomis macrochirus diagnosed with external columnaris disease. This bulletin summarizes the results of that trial.
Publication date
Type of document
Fact Sheet
Program
Species
FWS Focus